Jaclyn F. Hechtman

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.924Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4707

Top 22%

0.924DataRank

Top 22%38 citations

Samuel C. Nussenzweig, Henry Walch, Meier Hsu, Kay See Tan, Francisco Sánchez-Vega +16 more

Papers

Driven by 26 papers — median percentile 39. Top paper: “First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial”.

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30169-8

N/A

5.1DataRank · unranked

360 citations

Steven B. Maron, Walid K. Chatila, Brittanie M Millang, Shweta S. Chavan, Carly Alterman +20 more

Lineage Reversion Drives WNT Independence in Intestinal Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1536

N/A

2.6DataRank · unranked

84 citations

Sukanya Goswami, Yang Hu, Fanying Tang, María Paz Zafra, Charles J. Murphy +9 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.10.004

N/A

0.941DataRank · unranked

34 citations

Erika Gedvilaite, Ryan Ptashkin, Jason C. Chang, John Ziegler, Douglas A. Mata +14 more

Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4707

Top 22%

0.924DataRank

Top 22%38 citations

Samuel C. Nussenzweig, Henry Walch, Meier Hsu, Kay See Tan, Francisco Sánchez-Vega +16 more

ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1

Molecular Cell(2022)10.1016/j.molcel.2022.04.034

N/A

0.841DataRank · unranked

23 citations

Radha Mukherjee, Rona Yaeger, Jieun Son, Jianing Xu, Na Na +22 more

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Nature Communications(2021)10.1038/s41467-021-24109-5

N/A

0.782DataRank · unranked

183 citations

Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu +64 more

Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma

Hepatology(2021)10.1002/hep.31829

N/A

0.770DataRank · unranked

169 citations

Esther Drill, Linda M. Pak, Bastien Nguyen, Carlie Sigel, Alexandre Doussot +27 more

Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2278

N/A

0.724DataRank · unranked

124 citations

Melissa L. Johnson, Sarah Clifford, Romel Somwar, Jennifer Kherani, Jieun Son +23 more

TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0571

N/A

0.641DataRank · unranked

71 citations

Ji Eun Lee, Srinivasaraghavan Kannan, Alison M. Schram, Helen Won, Sophie Shifman +29 more

Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers

Nature Communications(2023)10.1038/s41467-022-35592-9

N/A

0.596DataRank · unranked

52 citations

Henry Walch, Jaclyn F. Hechtman, Sydney M. Moyer, Valeria Sgambati, David M. Faleck +23 more

Characterization and Clinical Outcomes of DNA Mismatch Repair–deficient Small Bowel Adenocarcinoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2892

N/A

0.584DataRank · unranked

48 citations

Jinru Shia, Zalak Patel, Diane Reidy‐Lagunes, Neil H. Segal, Rona Yaeger +20 more

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors

The Oncologist(2025)10.1093/oncolo/oyaf017

N/A

0.473DataRank · unranked

11 citations

Yonina R. Murciano‐Goroff, Antoine Desîlets, Guilherme Harada, Michael A. Postow, Margaret K. Callahan +9 more

Lineage reversion drives WNT independence in intestinal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.22.914689

N/A

0.385DataRank · unranked

12 citations

Sukanya Goswami, Yang Hu, Fanying Tang, María Paz Zafra, Charles J. Murphy +8 more

Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts

JCO Precision Oncology(2022)10.1200/po.21.00242

N/A

0.345DataRank · unranked

9 citations

Henry Walch, Marissa S. Mattar, Walid K. Chatila, Daniela Molena, Vivian E. Strong +10 more

Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4559

N/A

0.292DataRank · unranked

6 citations

Walid K. Chatila, Brittanie M Millang, Shalom Sabwa, Joanne F. Chou, Lilan Ling +15 more

Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4058

N/A

0.165DataRank · unranked

2 citations

Walid K. Chatila, Henry Walch, Ryan Ptashkin, Shalom Sabwa, Lilan Ling +13 more

Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1527

N/A

0.104DataRank · unranked

1 citations

Erin Salo‐Mullen, Amanda Catchings, Megha Ranganathan, Elise Fiala, Yelena Kemel +15 more

Data from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways

(2023)10.1158/1078-0432.c.6529997.v1

Top 100%

0DataRank

Top 100%0 citations

Samuel C. Nussenzweig, Henry Walch, Meier Hsu, Kay See Tan, Francisco Sánchez-Vega +16 more

SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis

Modern Pathology(2024)10.1016/j.modpat.2024.100585

N/A

0DataRank · unranked

17 citations

Kerem Özcan, Volkan Adsay, Serdar Balcı, Zeynep Tarcan, Jaclyn F. Hechtman +18 more

EGFRAmplification in Metastatic Colorectal Cancer

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab069

N/A

0DataRank · unranked

33 citations

Rona Yaeger, Jaclyn F. Hechtman, Paolo Manca, Giovanni Fucà, Henry Walch +21 more

Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients

Annals of Oncology(2020)10.1016/j.annonc.2020.04.008

N/A

0DataRank · unranked

33 citations

Bo Liu, Alison M. Schram, Pedram Razavi, Stephen M. Lagana, Y. Zhang +10 more

Early age of onset and broad cancer spectrum persist in MSH6 and PMS2-associated Lynch syndrome.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10516

N/A

0DataRank · unranked

0 citations

Karen A. Cadoo, Anna Maio, Zalak Patel, Yelena Kemel, Erin Salo‐Mullen +15 more

Carcinomas assemble a filamentous CXCL12–keratin-19 coating that suppresses T cell–mediated immune attack

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2119463119

N/A

0DataRank · unranked

72 citations

Philip Moresco, Ran Yan, Jiayun Li, Ya Gao, Daniele Biasci +8 more

Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack.

Apollo (University of Cambridge)(2022)10.17863/cam.81675

N/A

0DataRank · unranked

64 citations

Philip Moresco, Ran Yan, Jiayun Li, Ya Gao, Daniele Biasci +8 more

Data from Characterization and Clinical Outcomes of DNA Mismatch Repair–deficient Small Bowel Adenocarcinoma

(2023)10.1158/1078-0432.c.6529974

N/A

0DataRank · unranked

0 citations

Jinru Shia, Zalak Patel, Diane Reidy‐Lagunes, Neil H. Segal, Rona Yaeger +20 more

Jaclyn F. Hechtman

Indexed papers

Top data-sharing exemplar

Papers